DLHIX
Price
$28.36
Change
-$0.22 (-0.77%)
Updated
Nov 19 closing price
Net Assets
704.16M
FSPHX
Price
$30.27
Change
+$0.15 (+0.50%)
Updated
Nov 19 closing price
Net Assets
6.22B
Interact to see
Advertisement

DLHIX vs FSPHX

Header iconDLHIX vs FSPHX Comparison
Open Charts DLHIX vs FSPHXBanner chart's image
Macquarie Healthcare I
Price$28.36
Change-$0.22 (-0.77%)
VolumeN/A
Net Assets704.16M
Fidelity Select Health Care
Price$30.27
Change+$0.15 (+0.50%)
VolumeN/A
Net Assets6.22B
DLHIX vs FSPHX Comparison Chart in %
View a ticker or compare two or three
VS
DLHIX vs. FSPHX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLHIX is a Hold and FSPHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.22B vs. DLHIX (704M). DLHIX pays higher dividends than FSPHX: DLHIX (0.32) vs FSPHX (0.02). DLHIX was incepted earlier than FSPHX: DLHIX (18 years) vs FSPHX (44 years). DLHIX (1.01) is less costly to investors than FSPHX (0.63). FSPHX is a more actively managed with annual turnover of: 40.00 vs. DLHIX (5.00). DLHIX (0) and FSPHX (0) have matching initial minimum investment requirements. DLHIX annual gain was more profitable for investors over the last year : 4.78 vs. FSPHX (0.02). DLHIX return over 5 years is better than : 1.41 vs. FSPHX (-8.84).
DLHIXFSPHXDLHIX / FSPHX
Total Expense Ratio0.960.63152%
Annual Report Gross Expense Ratio1.010.63160%
Fund Existence18 years44 years-
Gain YTD18.11710.532172%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets704M6.22B11%
Annual Yield % from dividends0.320.022,042%
Returns for 1 year4.780.0228,300%
Returns for 3 years5.2410.4750%
Returns for 5 years1.41-8.84-16%
Returns for 10 years39.9539.34102%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CVTCX55.320.24
+0.44%
Calamos Growth & Income C
PEMGX42.33N/A
N/A
Principal MidCap A
BRUFX564.66N/A
N/A
Bruce
REMVX11.03N/A
N/A
RBC Emerging Markets Value Equity I
SPMHX8.48N/A
N/A
Invesco SteelPath MLP Alpha R5